Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Propofol-mediated Cardioprotection for Type II Diabetic Patients Undergoing Coronary Artery Bypass Surgery
FY 2009-10
Summary
Coronary artery bypass surgery bypasses blocked arteries of the heart to restore blood flow to the affected heart muscle. Patients with type II diabetes face an increased incidence of complications following bypass, and protective strategies are often limited in diabetics. This is primarily due to corrupted protective cellular signalling pathways in diabetic heart cells. Therefore, the cells within the diabetic heart have difficulties responding to damaging insults including oxidative stress, and commit cell death (apoptosis). Novel functions of the intravenous anaesthetic Propofol suggest a role for this drug to confer cardioprotection.
Recent work by our lab has demonstrated that propofol can activate the cell protective PI3K/Akt protein signalling pathway in heart cells. The mitochondrial permeability transition (mPT) pore is the main converging point of various cell-death signalling cascades, and its formation is directed by interplay between pro- and anti-survival members of the Bcl-2 family of proteins. Propofol is known to prevent mPT pore formation. We have shown that Propofol increases cellular levels of pro survival Bcl-2, a protein that prevents mPT pore formation. This action adds to the anti-oxidant protection already afforded by Propofol. The mechanism of how Propofol mediates protection to the heart cells is largely unknown. Further insight into its actions will allow us to better control and improve patient outlook during bypass surgery.
During my work as a masters student I will investigate the cellular signalling mechanism through which Propofol mediates cardioprotection. My work will focus on the effects of Propofol on the Bcl-2 protein family, and how they prevent mPT pore formation to produce a protective effect against apoptosis in the diabetic heart. Further understanding into the mechanisms of Propofol cardioprotection can be translated into more effective therapeutic interventions.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
200584
Name
Shravah Jayant
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Propofol-mediated Cardioprotection for Type II Diabetic Patients Undergoing Coronary Artery Bypass Surgery
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; Cardiopulmonary Bypass; Confocal Cellular Imaging; Elisa; Ischemia/Reperfusion Injury; Live Cell Imaging; Propofol; Tissue Culture; Western Blotting
Abstract
Coronary artery bypass surgery bypasses blocked arteries of the heart to restore blood flow to the affected heart muscle. Patients with type II diabetes face an increased incidence of complications following bypass, and protective strategies are often limited in diabetics. This is primarily due to corrupted protective cellular signalling pathways in diabetic heart cells. Therefore, the cells within the diabetic heart have difficulties responding to damaging insults including oxidative stress, and commit cell death (apoptosis). Novel functions of the intravenous anaesthetic Propofol suggest a role for this drug to confer cardioprotection.
Recent work by our lab has demonstrated that propofol can activate the cell protective PI3K/Akt protein signalling pathway in heart cells. The mitochondrial permeability transition (mPT) pore is the main converging point of various cell-death signalling cascades, and its formation is directed by interplay between pro- and anti-survival members of the Bcl-2 family of proteins. Propofol is known to prevent mPT pore formation. We have shown that Propofol increases cellular levels of pro survival Bcl-2, a protein that prevents mPT pore formation. This action adds to the anti-oxidant protection already afforded by Propofol. The mechanism of how Propofol mediates protection to the heart cells is largely unknown. Further insight into its actions will allow us to better control and improve patient outlook during bypass surgery.
During my work as a masters student I will investigate the cellular signalling mechanism through which Propofol mediates cardioprotection. My work will focus on the effects of Propofol on the Bcl-2 protein family, and how they prevent mPT pore formation to produce a protective effect against apoptosis in the diabetic heart. Further understanding into the mechanisms of Propofol cardioprotection can be translated into more effective therapeutic interventions.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shravah, Jayant
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~